The U.S. Food and Drug Administration’s outside vaccine advisers have voted unanimously in favour of authorizing both Moderna and Pfizer-BioNTech COVID-19 vaccines for children between six months and five years of age.
FDA advisers vote to authorize 2 COVID-19 vaccines for kids 5 and under in U.S.
